Burgess Julie 4
4 · Design Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Burgess Julie
Chief Accounting Officer
Transactions
- Award
Stock option (right to buy)
2025-01-02+135,000→ 135,000 totalExercise: $6.17Exp: 2035-01-01→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest as follows: 20% of the shares will vest on January 1, 2026, 20% of the shares will vest in equal monthly installments over the following 12 months, 30% of the shares will vest in equal monthly installments over the following 12 months, and 30% of the shares will vest in equal monthly installments over the following 12 months.